STOKE THERAPEUTICS APPOINTS BO CUMBO TO ITS BOARD OF DIRECTORS, ENHANCING COMMERCIAL EXPERTISE AS THE COMPANY ADVANCES ZOREVUNERSEN DEVELOPMENT TOWARD POTENTIAL FDA APPROVAL AND COMMERCIALIZATION

Reuters · 1d ago

Please log in to view news